As China steps up efforts to adapt its healthcare system to support an aging population, Swiss drugmaker Roche is expanding its neuroscience footprint in the country.

As China steps up efforts to adapt its healthcare system to support an aging population, Swiss drugmaker Roche is expanding its neuroscience footprint in the country.

As China steps up efforts to adapt its healthcare system to better support an aging population, Swiss drugmaker Roche is expanding its neuroscience footprint in the country.